
I have an extensive background in the private, public and third sectors. Previously working for over 10 years in the National Health Service and for last 14 years in the pharmaceutical industry.
Currently I am studying part time for my MBA and working as a Management Consultant specialising in Key Account Strategies to maximise sales effectiveness. These strategies include adopting new approaches to Key Accounts and building effective long terms partnerships with the NHS focusing on the customer not the product approach.
The pharmaceutical journals are awash with articles about changing the model of selling in the industry to one which is more customer centric key account focused one.
(Jul 25, 2009)Currently there are many discussions online and articles written about the need to change the model of selling in the pharmaceutical industry.
(Aug 1, 2009)I recently read a debate on a website which asked the question what is KAM in the pharmaceutical industry?
(Aug 9, 2009)During the course of my MBA studies I have been drawn to the subject of building learning organisations and managing the knowledge acquired through the learning process. This led me to consid
(Aug 14, 2009)Key account management continues to be a topic of hot debate, with Hanno last week asking the question are we doing it or just talking about it?
(Aug 23, 2009)Consistent changes within the NHS have continued to increase the distance between purchasers, prescribers and end users of medicines.
(Sep 6, 2009)Companies continue to down size reducing work force numbers for what ever reason, be it patent loss, contract loss or none approval of products by NICE or local bodies.
(Sep 13, 2009)Cited in Pharma Time this month are the results of the 2009 Survey of Market Research undertaken by QED Studios.
(Sep 21, 2009)The debate about Key Account Management (KAM) and its application within the pharmaceutical industry continues to evolve.
(Nov 12, 2009)The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs